Results of search for 'thematic-number:"Editorial"' › MedStar Authors Catalog catalog

Results
	1.	Intraperitoneal chemotherapy for peritoneal metastases: confronting diversity, maximizing benefit. MedStar authors: Sugarbaker, Paul H PMID: 33968421 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S1-S4, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-07 Add to cart (remove)
	2.	Prevention and Treatment of Peritoneal Metastases from Gastric Cancer. MedStar authors: Sugarbaker, Paul H PMID: 33924745 Year: 2021 Citation: Journal of Clinical Medicine. 10(9), 2021 Apr 28. Institution: Washington Cancer Institute Medline publication type: Editorial Form of publication: Journal Article All authors: Sugarbaker PH DOI: https://dx.doi.org/10.3390/jcm10091899xl - https://dx.doi.org/10.3390/jcm10091899 Add to cart (remove)
	3.	"Total Mesenteric Peritonectomy for Peritoneal Metastases" (with Video) by Jean-Baptiste Cazauran et al. MedStar authors: Sugarbaker, Paul H PMID: 29019119 Year: 2017 Citation: Annals of Surgical Oncology. 24(13):3799-3800, 2017 12. Institution: Washington Cancer Institute Medline publication type: Editorial Form of publication: Journal Article All authors: Sugarbaker PH DOI: https://dx.doi.org/10.1245/s10434-017-6100-3 Add to cart (remove)
	4.	Integration of Cytoreductive Surgery and Perioperative Chemotherapy into the Multidisciplinary Management of Intra-Abdominal Cancer. MedStar authors: Sugarbaker, Paul H PMID: 35614897 Year: 2022 Citation: Visceral Medicine. 38(2):79-80, 2022 Apr. Institution: Washington Cancer Institute Medline publication type: Editorial Form of publication: Journal Article All authors: Sugarbaker PH DOI: https://dx.doi.org/10.1159/000522605 Add to cart (remove)
	5.	The Seven Best from PSOGI 2016. MedStar authors: Sugarbaker, Paul H PMID: 28168384 Year: 2017 Citation: Annals of Surgical Oncology. 24(4):870-874, 2017 Apr Institution: Washington Cancer Institute Medline publication type: Editorial Form of publication: Journal Article All authors: Sugarbaker PH DOI: https://dx.doi.org/10.1245/s10434-017-5793-7 Add to cart (remove)
	6.	A model for accurate histopathologic assessment refines treatment options. MedStar authors: Sugarbaker, Paul H PMID: 33970168 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S230, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-20 Add to cart (remove)
	7.	Super-responders to bidirectional neoadjuvant chemotherapy showed prolonged survival. MedStar authors: Sugarbaker, Paul H PMID: 33970162 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S57-S58, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-11 Add to cart (remove)
	8.	Current data is sufficient to recommend a current standard of care. MedStar authors: Sugarbaker, Paul H PMID: 33970154 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S45-S46, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-10 Add to cart (remove)
	9.	Peritoneal progression after pancreaticoduodenectomy is a devastating surgical treatment failure: HIPEC gemcitabine is an option. MedStar authors: Sugarbaker, Paul H PMID: 33970167 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S118-S119, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-14 Add to cart (remove)
	10.	Cashin and Graf: long-term intraperitoneal 5-fluorouracil is superior to adjuvant FOLFOX in a randomized trial. MedStar authors: Sugarbaker, Paul H PMID: 33970155 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S136, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-16 Add to cart (remove)
	11.	The options are neoadjuvant, adjuvant, or no chemotherapy at all: further data is needed. MedStar authors: Sugarbaker, Paul H PMID: 33970152 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S214-S215, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-19 Add to cart (remove)
	12.	Knowledgeable case selection results in favorable outcomes. MedStar authors: Sugarbaker, Paul H PMID: 33970169 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S30-S31, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-09 Add to cart (remove)
	13.	Ovarian cancer with peritoneal metastases has many treatment options and HIPEC is here to stay. MedStar authors: Sugarbaker, Paul H PMID: 33970163 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S189-S190, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-17 Add to cart (remove)
	14.	Adjuvant HIPEC for gastric cancer. MedStar authors: Sugarbaker, Paul H PMID: 33970159 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S18-S19, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-08 Add to cart (remove)
	15.	The PRODIGE 7 randomized trial has 4 design flaws and 4 pharmacologic flaws and cannot be used to discredit other HIPEC regimens. MedStar authors: Sugarbaker, Paul H PMID: 33970156 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S129-S130, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-15 Add to cart (remove)
	16.	Genetic targets for cancer control are a reality. MedStar authors: Sugarbaker, Paul H PMID: 33970166 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S204-S205, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-18 Add to cart (remove)
	17.	PIPAC may work but more data is needed. MedStar authors: Sugarbaker, Paul H PMID: 33970164 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S271-S272, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-22 Add to cart (remove)
	18.	Aggressive local treatments may prolong survival but do not have curative intent. MedStar authors: Sugarbaker, Paul H PMID: 33970158 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S68-S69, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-12 Add to cart (remove)
	19.	Paclitaxel is the pharmacologic near perfect chemotherapy for peritoneal metastases. MedStar authors: Sugarbaker, Paul H PMID: 33970160 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S240-S241, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-21 Add to cart (remove)
	20.	Single institution best recommendation is HIPEC with cisplatin and docetaxel. MedStar authors: Sugarbaker, Paul H PMID: 33970157 Year: 2021 Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S79, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Sugarbaker PH, Van der Speeten K DOI: https://dx.doi.org/10.21037/jgo-2020-13 Add to cart (remove)
	21.	Protocols versus practice in the management of colorectal peritoneal metastases. MedStar authors: Ghabra, Shadin Sugarbaker, Paul H PMID: 35289933 Year: 2022 Citation: Journal of Surgical Oncology. 2022 Mar 15 Institution: Washington Cancer Institute Department: MedStar General Surgery Residency MedStar Georgetown University Hospital/MedStar Washington Hospital Center Medline publication type: Editorial Form of publication: Journal Article All authors: Ghabra S, Sugarbaker PH DOI: https://dx.doi.org/10.1002/jso.26848 Add to cart (remove)

Refine your search

Authors

Item types

Topics

Collections

Languages

Your search returned 21 results.